GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Mural Oncology PLC (NAS:MURA) » Definitions » FCF Yield %

MURA (Mural Oncology) FCF Yield % : -297.66 (As of Sep. 24, 2024)


View and export this data going back to 2023. Start your Free Trial

What is Mural Oncology FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Mural Oncology's Trailing 12-Month Free Cash Flow is $-162.29 Mil, and Market Cap is $54.52 Mil. Therefore, Mural Oncology's FCF Yield % for today is -297.66%.

The historical rank and industry rank for Mural Oncology's FCF Yield % or its related term are showing as below:

MURA' s FCF Yield % Range Over the Past 10 Years
Min: -364.62   Med: 0   Max: 0
Current: -297.66

MURA's FCF Yield % is ranked worse than
94.26% of 1534 companies
in the Biotechnology industry
Industry Median: -13.655 vs MURA: -297.66

Mural Oncology's FCF Margin % for the quarter that ended in Jun. 2024 was 0.00%.

Mural Oncology FCF Yield % Historical Data

The historical data trend for Mural Oncology's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mural Oncology FCF Yield % Chart

Mural Oncology Annual Data
Trend Dec21 Dec22 Dec23
FCF Yield %
- - -200.10

Mural Oncology Quarterly Data
Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only - - -177.74 -180.75 -220.95

Competitive Comparison of Mural Oncology's FCF Yield %

For the Biotechnology subindustry, Mural Oncology's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Mural Oncology's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Mural Oncology's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Mural Oncology's FCF Yield % falls into.


Mural Oncology FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Mural Oncology's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-197.701 / 98.803024
=-200.10%

Mural Oncology's annualized FCF Yield % for the quarter that ended in Jun. 2024 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-29.359 * 4 / 53.151094
=-220.95%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Mural Oncology FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Mural Oncology FCF Yield % Related Terms

Thank you for viewing the detailed overview of Mural Oncology's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Mural Oncology Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Mural Oncology PLC (NAS:MURA) » Definitions » FCF Yield %
Comparable Companies
Traded in Other Exchanges
N/A
Address
10 Earlsfort Terrace, Dublin, IRL, D02 T380
Website
Mural Oncology PLC is a clinical-stage oncology company whose entire business is focused on discovering and developing immunotherapies that may meaningfully improve the lives of patients with cancer. By leveraging their core competencies in immune cell modulation and protein engineering, It has developed a portfolio of novel, investigational cytokine therapies designed to address areas of unmet need for patients with a variety of cancers. The Company operates as one business segment, which is the business of developing medicines designed to address unmet medical needs of patients in the area of oncology.